Djalilian AR - Search Results

1

Cellular senescence implication in mustard keratopathy.

Soleimani M, Baharnoori SM, Cheraqpour K, Momenaei B, Mirshahi R, Chow C, Shahjahan S, Nguyen T, Ashraf MJ, Huang X, Koganti R, Cheraghpour M, Ghassemi M, Djalilian AR. Soleimani M, et al. Among authors: djalilian ar. Exp Eye Res. 2023 Aug;233:109565. doi: 10.1016/j.exer.2023.109565. Epub 2023 Jul 3. Exp Eye Res. 2023. PMID: 37406956

2

Survival of donor epithelial cells after limbal stem cell transplantation.

Djalilian AR, Mahesh SP, Koch CA, Nussenblatt RB, Shen D, Zhuang Z, Holland EJ, Chan CC. Djalilian AR, et al. Invest Ophthalmol Vis Sci. 2005 Mar;46(3):803-7. doi: 10.1167/iovs.04-0575. Invest Ophthalmol Vis Sci. 2005. PMID: 15728534

3

Comparison between the refractive results of combined penetrating keratoplasty/transsclerally sutured posterior chamber lens implantation and the triple procedure.

Djalilian AR, George JE, Doughman DJ, Holland EJ. Djalilian AR, et al. Cornea. 1997 May;16(3):319-21. Cornea. 1997. PMID: 9143805

4

Mycophenolate mofetil for the treatment of scleritis.

Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Sen HN, et al. Among authors: djalilian ar. Ophthalmology. 2003 Sep;110(9):1750-5. doi: 10.1016/S0161-6420(03)00570-0. Ophthalmology. 2003. PMID: 13129873 Clinical Trial.

5

Histopathology and treatment of corneal disease in keratitis, ichthyosis, and deafness (KID) syndrome.

Djalilian AR, Kim JY, Saeed HN, Holland EJ, Chan CC. Djalilian AR, et al. Eye (Lond). 2010 Apr;24(4):738-40. doi: 10.1038/eye.2009.178. Epub 2009 Jul 10. Eye (Lond). 2010. PMID: 19590522 Free PMC article. No abstract available.

6

Feline immunodeficiency virus-mediated gene therapy of middle ear mucosa cells.

Djalilian HR, Tsuboi Y, Ozeki M, Tekin M, Djalilian AR, Obritch W, Lin J. Djalilian HR, et al. Among authors: djalilian ar. Auris Nasus Larynx. 2002 Apr;29(2):183-6. doi: 10.1016/s0385-8146(01)00131-6. Auris Nasus Larynx. 2002. PMID: 11893454

7

Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response.

Djalilian AR, McGaughey D, Patel S, Seo EY, Yang C, Cheng J, Tomic M, Sinha S, Ishida-Yamamoto A, Segre JA. Djalilian AR, et al. J Clin Invest. 2006 May;116(5):1243-53. doi: 10.1172/JCI27186. Epub 2006 Apr 20. J Clin Invest. 2006. PMID: 16628254 Free PMC article.

8

Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.

Holland EJ, Djalilian AR, Sanderson JP. Holland EJ, et al. Among authors: djalilian ar. Cornea. 2009 Dec;28(10):1139-43. doi: 10.1097/ICO.0b013e3181a3c52f. Cornea. 2009. PMID: 19770719

9

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.

Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR. Nussenblatt RB, et al. J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6. J Autoimmun. 2003. PMID: 14599854 Clinical Trial.

10

Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration.

Djalilian AR, Cantrill HC, Samuelson TW. Djalilian AR, et al. Eur J Ophthalmol. 2003 Jan-Feb;13(1):96-8. doi: 10.1177/112067210301300117. Eur J Ophthalmol. 2003. PMID: 12635684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page